Skip to content

Clinical study on the treatment of lumbar intervertebral disc herniation by ultrasound-guided electroacupuncture at the dorsal root ganglion based on neuroregulation theory

Research on the Efficacy and Mechanism of Ultrasound-Guided Electroacupuncture Stimulation of Dorsal Root Ganglion Based on Neuromodulation Theory in the Treatment of Lumbar Disc Herniation

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ITMCTR
Registry ID
ITMCTR2026001041
Enrollment
Unknown
Registered
2026-04-22
Start date
2026-05-01
Completion date
Unknown
Last updated
2026-04-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Lumbar disc herniation

Interventions

Experimental group:Ultrasound-guided electroacupuncture treatment of the dorsal root ganglion
Control group:Conventional acupoint electro - acupuncture treatment is adopted.

Sponsors

The Second People's Hospital of Zhangjiagang City
Lead Sponsor

Eligibility

Sex/Gender
All
Age
20 Years to 85 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria: 1) Patients with a definite diagnosis of lumbar disc herniation and a disease duration of less than 36 months; 2) Aged between 20 and 85 years; 3) Patients agree to participate in the trial and sign the informed consent form for the clinical trial.

Exclusion criteria

Exclusion criteria: Exclusion criteria: 1) Patients with combined lumbar spinal stenosis, lumbar spondylolisthesis of degree II or above, or a history of open lumbar spine surgery; 2) Patients with fever, systemic infection, or infection foci at or around the operation site; 3) Patients in the attack period of severe visceral diseases, those with severe hypertension, diabetes, severe osteoporosis, or coronary heart disease; 4) Patients with a bleeding tendency or coagulation dysfunction; 5) Pregnant women, patients with mental illness, dementia, malignant tumors, or intraspinal tumors; 6) Patients with an unclear localization diagnosis; 7) Patients who use other drugs or treatments that may affect the evaluation of curative effects during the research process; 8) Subjects who withdraw from the study before treatment after enrollment.

Design outcomes

Primary

MeasureTime frame
Japanese Orthopaedic Association (JOA) Low Back Pain Score;

Secondary

MeasureTime frame
Oswestry Disability Index;Visual Analog Scale (VAS) score;36 - Item Short - Form Health Survey (SF - 36);Improvement of MacNab efficacy assessment;

Countries

China

Contacts

Public ContactYe Cao

The Second People's Hospital of Zhangjiagang City

caoyezongkehong@126.com13962237065

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: May 1, 2026